68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial

Summary

The purpose of this study is to use a new type of scan, called 68Ga-DOTATOC PET/CT scan, instead of OctreoScan, the standard scan, to diagnose, monitor and manage your tumor. 68Ga-DOTATOC is an improved imaging agent being routinely used in many centers outside the USA, with better tumor detection than with OctreoScan.

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications